GeneDx Holdings (WGS) Total Non-Current Liabilities (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Total Non-Current Liabilities data on file, last reported at $252.1 million in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $252.1 million, up 38.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $252.1 million (up 38.21% YoY), and the FY2025 annual result was $213.9 million, up 26.85% from the prior year.
• Total Non-Current Liabilities rose to $252.1 million in Q1 2026 per WGS's latest filing, from $213.9 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $288.7 million in Q2 2022 and troughed at $140.4 million in Q3 2023.
• A 5-year average of $198.7 million and a median of $184.8 million in 2022 frame the typical range for Total Non-Current Liabilities.
• On a YoY basis, Total Non-Current Liabilities climbed as much as 74.37% in 2022 and fell as far as 54.55% in 2022.
• A 5-year view of Total Non-Current Liabilities shows it stood at $213.2 million in 2022, then decreased by 17.45% to $176.0 million in 2023, then declined by 4.2% to $168.6 million in 2024, then climbed by 26.85% to $213.9 million in 2025, then advanced by 17.87% to $252.1 million in 2026.
• Business Quant data shows WGS's Total Non-Current Liabilities at $252.1 million in Q1 2026, $213.9 million in Q4 2025, and $197.4 million in Q3 2025.